| Financial Year |
March 31 2023 |
| Monetary Funds |
294,685,542.35 |
| Held-for-trading Financial Assets |
10,591,801.34 |
| Notes Receivable |
83,289,793.93 |
| Accounts Receivable |
445,518,554.55 |
| Advances to Suppliers |
4,994,419.36 |
| Other Receivables |
9,022,589.60 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
338,326,167.38 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
58,119,051.62 |
| Total Current Assets |
1,268,786,747.79 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
2,630,000.00 |
| Long-term Equity Investment |
20,318,146.37 |
| Investment Properties |
-- |
| Fixed Assetes |
1,041,154,315.12 |
| Under-construction Projects |
157,468,357.75 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
39,521,554.30 |
| R&D expenses |
15,928,591.55 |
| Goodwill |
13,769,406.56 |
| Long-Term Deferred and Prepaid Expenses |
32,464,369.18 |
| Deferred Income Tax Assets |
65,137,330.21 |
| Other Non-Current Assets |
31,855,895.31 |
| Sub-Total of Non-Current Assets |
1,441,115,156.14 |
| Total Assets |
2,709,901,903.93 |
| Short-Term Loans |
304,735,237.83 |
| Trading Financial liabilities |
-- |
| Notes Payable |
217,577,365.14 |
| Accounts Payable |
283,296,873.24 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
23,103,725.99 |
| Taxes Payable |
8,249,540.54 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
14,415,404.76 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
89,109,752.23 |
| Other Current Liabilities |
71,112,459.94 |
| Sub-Total of Current Liabilities |
1,021,881,815.47 |
| Long-term Loans |
263,175,816.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
115,920,733.48 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
18,816,272.91 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
456,950,513.93 |
| Total Liabilities |
1,478,832,329.40 |
| Paid-In Capital(Or Share Stock) |
690,423,600.00 |
| Capital Surplus |
231,741,097.91 |
| Surplus Reserve |
49,725,035.06 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
116,135,789.78 |
| Minority Stockholder's Interest |
144,010,559.58 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,087,059,014.95 |
| Owner's Equity（Stockholder's Equity） |
1,231,069,574.53 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,709,901,903.93 |
